Available from: Yang Z, Yu M, Mei M, Chen C, Lv Y, Xiang L, et al
Interested parties can learn more at Roughly 1 in 8 American adults are taking GLP-1 drugs like Ozempic or Wegovy to lose weight or treat a chronic condition, according to data from the Kaiser Family Foundation
Kidney Issues: There have been reports of kidney-related problems, including acute kidney injury (especially in patients who are dehydrated)
In short, the very thing that makes GLP-1 drugs so effective for weight loss appetite suppression can be a major disadvantage for anyone trying to train hard or compete
The person its going to harm is the person for whom is nobodys considering that is not looking at that piece, right